References
- 1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 1982, 51:189-199.
- 2. Cazzola M, Malcovati L: Myelodysplastic syndromes -coping with ineffective hematopoiesis. N Engl J Med, 2005, 352: 536-538.
- 3. Vardiman JW, Harris NL, Brunning RD: The new World Health Organization classification of myeloid neoplasms: Blood, 2002, 100:2292-2302.
- 4. Fenaux P: Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. SeminHematol., 2004;41:6-12.
- 5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G: International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes. Blood, 1997; 89:2079-2088.
- 6. Greenberg P, Tuechler H, Schanz J, Sanz G, Solé F, Bennett J et al: Revised International Prognostic Scoring System for Myelodysplastic Syndromes. Blood, 2012 120: 2454-2465.
- 7. Swansbury J: Methods in Molecular Biology TMCancer Cytogenetics Methods and Protocols.Humana, 2003;220: 43-56.
- 8. Shaffer LG, Slovak ML, Campbell JL: An International System for Human Cytogenetic Nomenclature, 2009.
- 9. Nowell PC. Chromosome abnormalities in myelodysplastic syndromes. SeminOncol, 1992;19:1925-1929.
- 10. Haase D, Germing U, Schanz J, Pfeilstöcker M, Nösslinger T, Steidl N: New insights into the prognostic impact of the karyotype in MDS andcorrelation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007, 110: 4385-4395
- 11. De Witte T, Hermans J, Vossen J, Bacigalupo A., Meloni G., Jacobsen N. et al:Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).Br J Haematol,2000;110:620-630.